Ten post jest także dostępny w języku: polski
More than PLN 7m of funding will go to NEO Hospital from the ROP WM funds. The company will carry out cervical and uterine stem (endometrial) cancer surgeries using the TMMR/PMMR method with the use of da Vinci robot.
Da Vinci robot in gynaecology
The NEO Hospital Group will begin the implementation of the operation project using the da Vinci robot of cervical and uterine stem cancers with co-financing from the Regional Operational Programme of the Małopolska Region (ROP WM). The total cost of the project is nearly PLN 12.6m, of which more than PLN 7.3m is co-financed from EU funds. Within the framework of the project, Krakow Szpital na Klinach, belonging to the NEO Hospital Group, will perform 200 procedures, including 100 in the group of patients with cervical cancer and 100 in the group of patients with endometrial cancer. The treatments will be completely free of charge for patients qualified to the programme.
According to the presented guidelines, patients with diagnosed cervical or endometrial cancer at the stage requiring radical surgery can participate in the project. The programme has been launched since 2 January 2021, and qualification for the programme has already begun.
Revolution in treatment?
The TMMR/PMMR method (TMMR refers to the treatment of cervical cancer and PMMR refers to the treatment of endometrial cancer) performed with the da Vinci robot is a breakthrough in the minimally invasive surgical treatment of cervical and endometrial cancers.
– Comparison of the results of early-stage surgical treatment of cervical and uterine stem cancer using the TMMR/PMMR method with the results of standard surgical treatment according to the current oncological protocol will allow the introduction of a new, innovative process of cervical and uterine stem cancer treatment. The use of da Vinci robot is also important in the programme. Patients will receive a minimally invasive procedure, and at the same time characterized by high precision, thanks to which it is possible to completely remove the cancer and maintain the patient’s high quality of life after the operation. The possibility of using the da Vinci robot in surgical treatment is also particularly important for patients with a significant degree of obesity, which hinders gynaecological operations – says Prof. KAAFM, Pawel Szymanowski, PhD, specialist in obstetrics and gynaecology from NEO Hospital in Krakow, Head of the Gynaecology and Obstetrics Clinic of the Faculty of Medicine and Health Sciences of the Andrzej Frycz Modrzewski Krakow Academy.